London Daily

Focus on the big picture.
Saturday, Jul 26, 2025

Scientists take ‘important step’ in stem cell therapy to treat Parkinson’s

Scientists take ‘important step’ in stem cell therapy to treat Parkinson’s

Chinese Academy of Sciences team discovered a new technique they say improved efficacy and safety in study on mice.

Chinese researchers have discovered a new technique they say improved the efficacy and safety of stem cell therapy in mice models of Parkinson’s disease.

The team from the Chinese Academy of Sciences (CAS) said their study findings paved the way for potentially developing a stem cell therapy to treat the disease.

The researchers identified two cell surface markers of dopamine neurons, which are damaged or destroyed in the midbrain of someone with Parkinson’s disease.

They then injected cells with these markers into the brains of mice, which they found could significantly improve the dopamine neurons in the midbrain – a key step in the treatment of the disease.

The finding “represents a revolutionary step on the road towards more effective and safer stem cell therapies”, according to the study, published in the Journal of Clinical Investigation on Tuesday.




Neurological disorders are the leading source of disability globally, and Parkinson’s disease is the second most common neurodegenerative disorder after Alzheimer’s. There is no cure for Parkinson’s disease, but the symptoms can be managed with medications and other therapies.

Worldwide, some 6.1 million people had Parkinson’s disease in 2016, according to the Lancet’s Global Burden of Disease Study in 2018. That number is expected to double to more than 12 million by 2040.

In China, it is estimated that the number of Parkinson’s disease patients could rise to about 5 million by 2030, accounting for half of the world’s cases.

Parkinson’s disease is a degenerative disorder affected by the impairment or death of cells in deep parts of the brain called the substantia nigra, which produces the neurotransmitter dopamine and controls body movement.

When 60 to 80 per cent of dopamine is lost, Parkinson’s symptoms such as tremor and balance problems occur.

Stem cell therapy is considered to be a promising treatment strategy because the disease is caused by the loss of one type of cell from a certain spot in the brain.

“Parkinson’s disease is the most suitable one [for stem cell therapy] because it is very clear which cells are lost and where should they be transplanted,” said Chen Yuejun, corresponding author of the study and a researcher with the CAS.

However, previous studies have generated both target and off-target neuronal cells during transplantation, resulting in low efficacy and uncertainty around safety.

“Our study wanted to answer two questions – why the previous studies generated more than a dozen off-target cells, and how we could enrich [certain] cells,” said Chen, who heads the Laboratory of Neural Differentiation and Regeneration at the CAS.

Stem cell therapy is seen as a promising strategy to treat Parkinson’s disease.


Chen and the team did a single-cell sequencing of dopaminergic neurons and found that the off-target cells were generated in areas near the midbrain.

They also found two markers that could facilitate highly enriched dopaminergic neurons after transplantation.

The percentage of neurons could be as high as 80 per cent in the transplant area, according to the paper. That compares to about 10 per cent in two recent preclinical studies.

“The study established a method for obtaining highly purified donor cells that can be transplanted with stable and predictable cell therapy results,” the authors said in a statement on the CAS website.

“It is an important step towards more effective and safer cell therapy for Parkinson’s disease.”

Newsletter

Related Articles

0:00
0:00
Close
Deputy attorney general's second day of meeting with Ghislaine Maxwell has concluded
Controversial March in Switzerland Features Men Dressed in Nazi Uniforms
Politics is a good business: Barack Obama’s Reported Net Worth Growth, 1990–2025
Thai Civilian Death Toll Rises to 12 in Cambodian Cross-Border Attacks
TSUNAMI: Trump Just Crossed the Rubicon—And There’s No Turning Back
Over 120 Criminal Cases Dismissed in Boston Amid Public Defender Shortage
UN's Top Court Declares Environmental Protection a Legal Obligation Under International Law
"Crazy Thing": OpenAI's Sam Altman Warns Of AI Voice Fraud Crisis In Banking
The Podcaster Who Accidentally Revealed He Earns Over $10 Million a Year
Trump Announces $550 Billion Japanese Investment and New Trade Agreements with Indonesia and the Philippines
US Treasury Secretary Calls for Institutional Review of Federal Reserve Amid AI‑Driven Growth Expectations
UK Government Considers Dropping Demand for Apple Encryption Backdoor
Severe Flooding in South Korea Claims Lives Amid Ongoing Rescue Operations
Japanese Man Discovers Family Connection Through DNA Testing After Decades of Separation
Russia Signals Openness to Ukraine Peace Talks Amid Escalating Drone Warfare
Switzerland Implements Ban on Mammography Screening
Japanese Prime Minister Vows to Stay After Coalition Loses Upper House Majority
Pogacar Extends Dominance with Stage Fifteen Triumph at Tour de France
CEO Resigns Amid Controversy Over Relationship with HR Executive
Man Dies After Being Pulled Into MRI Machine Due to Metal Chain in New York Clinic
NVIDIA Achieves $4 Trillion Valuation Amid AI Demand
US Revokes Visas of Brazilian Corrupted Judges Amid Fake Bolsonaro Investigation
U.S. Congress Approves Rescissions Act Cutting Federal Funding for NPR and PBS
North Korea Restricts Foreign Tourist Access to New Seaside Resort
Brazil's Supreme Court Imposes Radical Restrictions on Former President Bolsonaro
Centrist Criticism of von der Leyen Resurfaces as she Survives EU Confidence Vote
Judge Criticizes DOJ Over Secrecy in Dropping Charges Against Gang Leader
Apple Closes $16.5 Billion Tax Dispute With Ireland
Von der Leyen Faces Setback Over €2 Trillion EU Budget Proposal
UK and Germany Collaborate on Global Military Equipment Sales
Trump Plans Over 10% Tariffs on African and Caribbean Nations
Flying Taxi CEO Reclaims Billionaire Status After Stock Surge
Epstein Files Deepen Republican Party Divide
Zuckerberg Faces $8 Billion Privacy Lawsuit From Meta Shareholders
FIFA Pressured to Rethink World Cup Calendar Due to Climate Change
SpaceX Nears $400 Billion Valuation With New Share Sale
Microsoft, US Lab to Use AI for Faster Nuclear Plant Licensing
Trump Walks Back Talk of Firing Fed Chair Jerome Powell
Zelensky Reshuffles Cabinet to Win Support at Home and in Washington
"Can You Hit Moscow?" Trump Asked Zelensky To Make Putin "Feel The Pain"
Irish Tech Worker Detained 100 days by US Authorities for Overstaying Visa
Dimon Warns on Fed Independence as Trump Administration Eyes Powell’s Succession
Church of England Removes 1991 Sexuality Guidelines from Clergy Selection
Superman Franchise Achieves Success with Latest Release
Hungary's Viktor Orban Rejects Agreements on Illegal Migration
Jeff Bezos Considers Purchasing Condé Nast as a Wedding Gift
Ghislaine Maxwell Says She’s Ready to Testify Before Congress on Epstein’s Criminal Empire
Bal des Pompiers: A Celebration of Community and Firefighter Culture in France
FBI Chief Kash Patel Denies Resignation Speculations Amid Epstein List Controversy
Air India Pilot’s Mental Health Records Under Scrutiny
×